Spots Global Cancer Trial Database for GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
Official Title: Surgical Effects of GnRH Agonist Pretreatment on Cold Loop Hysteroscopic Myomectomy.
Study ID: NCT01873378
Conditions
Interventions
Study Description
Brief Summary: The primary outcome of this study is to assess if the GnRHa administration before cold loop hysteroscopic myomectomy contributes to accomplish the treatment in only one surgical procedure. Moreover, we will investigate the intraoperative influence of such pharmacologic therapy in terms of distension liquid absorption and duration of the procedures.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Arbor Vitae Endoscopic Centre, Rome, , Italy
Contact Details
Name: sandro gerli, MD
Affiliation: University of Perugia, Perugia, Italy
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
